The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Safe Sex and HIV PreventionSafe Sex and HIV Prevention
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

meds impacting transmission statistics?

Jun 12, 2004

"The risk for HIV transmission per episode of receptive penile-anal sexual exposure with an HIV-positive partner is estimated at 0.1% to 3%."

Would this risk be higher if HAART was never developed?

Is HIV in the third world more easily transmitted due to a higher average viral load, since most of the infected are not on HAART?

Response from Dr. Frascino


Let me give your some data from a very recent study from UCSF (University of California, San Francisco), my alma mater. A 2004 study of young gay men spanning the advent of HAART (1994 to 1999) concluded that meds reduce HIV transmission by 60%. That's the good news! The bad news from the same UCSF HAART study showed that these young guys engaged in twice as much unprotected anal sex, causing the HIV infection rate to plateau instead of plunge. I'll let you draw you own conclusions from that data.

Dr. Bob

Je suis fini: j'ai rate ma vie..
Permission de "ah-wouhou-er" ?

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint